View Archive

Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Genentech, Inc.

Bladder Cancer Playbook for Urologists: Practical Application of Current and Emerging Strategies to Optimize Patient Outcomes

Bladder Cancer Playbook for Urologists: Practical Application of Current and Emerging Strategies to Optimize Patient Outcomes

Thursday, June 4th, 2020

Live Webcast: 8:00 PM – 10:00 PM ET


The treatment landscape of bladder cancer continues to progress with advances in immuno-oncology and targeted therapy strategies, and new clinical data continues to impact all stages of bladder cancer with the use of single-agent and combination immunotherapy approaches. In addition, novel agents that address bladder cancer with specific genomic alterations are being explored, as well as therapeutic options for disease that is refractory to immune checkpoint inhibitor therapy.

This live webcast features a panel of experts who will address the application of immune-based and targeted agent approaches through presentations and discussions of the most recent clinical data for the treatment of early and advanced bladder cancer. Practical patient case scenarios will highlight treatment decisions in various settings of bladder cancer and will address adverse event management of immunotherapy and targeted agents, the importance of multidisciplinary care, and future directions in the field of bladder cancer.

Benefits of Attending

  • Hear experts talk about new therapies
  • Gain insights regarding immune-related adverse events
  • Learn about novel single-agent and combination strategies
  • Be in the know of the treatment pipeline

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Genentech, Inc.

Target Audience

This educational program is directed toward urologists, oncologists, and researchers interested in the treatment of bladder cancers. Nurse practitioners, physician assistants, nurses, and other health care professionals involved in the treatment and management of patients with bladder cancers will be invited to participate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Identify the biologic rationale for using immune-based and targeted therapy approaches to treat bladder cancer
  • Evaluate data from pivotal clinical trials of immunotherapies, signaling inhibitors, and other emerging agents for bladder cancer
  • Discuss novel agents and combinatorial approaches under investigation for the treatment of bladder cancer across multiple settings, including advanced/metastatic, muscle-invasive, and non–muscle-invasive disease
  • Consider practice-changing evidence from clinical trials of immunotherapies, cytotoxic agents, and targeted therapies during multidisciplinary, team-based care planning for patients with bladder cancer
  • Outline frequent and less common toxicities associated with newer agents used in the treatment of bladder cancer, including immunotherapies and targeted agents, and best practices for their mitigation and management

Program Chair

Robert Dreicer, MD, MS, MACP, FASCO
Robert Dreicer, MD, MS, MACP, FASCO
Professor of Medicine and Urology
University of Virginia School of Medicine
Section Head, Medical Oncology
Associate Director for Clinical Research
Deputy Director, University of Virginia Cancer Center
Co-Director, Paul Mellon Urologic Cancer Institute
Charlottesville, VA


2 Ways to Register
  1. Online: Click here.
  2. Phone: Please call +1-(888)-949-0045 or +1-(609)-378-3701.
Physicians' Education Resource®, LLC
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By